CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,995 enrolled
Drug / intervention
Pantoprazoledrug
Likely dose
Pantoprazole 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00561730
NCT00561730N/ACompleted
CompareCT.gov

Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)

Nycomed·observational·Posted Nov 21, 2007·Updated May 8, 2012

In Brief

An observational study evaluating Pantoprazole for Gastroesophageal Reflux Disease. Completed, enrolled 1,995 participants across 259 sites.

Detailed Summary

The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 21, 2007
Enrollment StartOct 1, 2007
Study CompletionDec 1, 2008
TodayJul 2, 2026
Posted 18.6 years ago

Interventions

Pantoprazoledrug

Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).